Prostatitis

Abstract

The objective of this article is to present a detailed review of the international literature concerning both the already established and the most recent information about clinical picture, aetiology, classi®cation, diagnosis and treatment of prostatitis.The symptomatology of the condition is non-speci®c and requires a wide spectrum of diagnostic tools in order the clinician be able to reach a ®rm conclusion. A novel classi®cation system is outlined, with already established international reputation.The treatment of the various chronic types is often empirical and the available therapies need controlled studies in order to achieve an established status in Urologist's armamentarium.Finally it is emphasized that continuous research addressing to aetiology, pathogenesis, diagnosis and treatment is of paramount importance in answering questions and shedding light on this obscure syndrome.

Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer

“…Retrospective studies of prostatitis are vulnerable to misclassification bias, as clinical signs and symptoms are variable and diagnoses are often uncertain. 1,35 Detection bias also appears to be an issue; in our study, clinical prostatitis was only associated with prostate cancer risk in white men with a high frequency of PSA testing. Interestingly, PSA testing frequency did not show a similar effect in African Americans, which may be explained in part by the racial differences in PSA production, perhaps amplified in the presence of prostatic inflammation.…”

“…1 The National Institutes of Health (NIH) classifies prostatitis into four categories: 2 Types I–III are symptomatic; in contrast, Type IV is asymptomatic and detected only upon histological examination of a prostate specimen. 3 Acute prostatitis (Type I) is more common in younger men, 4 whereas chronic prostatitis (Types II–IV) is associated with increasing age.…”

Studying clinical of efficiency α-adrenoblockator tamsulozinum at men at of the chronic abacterial prostatitis or chronic pelvic pain syndrome

“…Следует отметить, что антибактериальную терапию необ ходимо рекомендовать при наличии определенных клиничес ких, бактериологических или иммунологических признаков инфекции в простатовезикулярном комплексе [2,22]. Необхо димо учитывать, что некоторые уропатогены нижнего мочевого тракта, которые обычно не получают клинической реализации, в определенных условиях становятся патогенными [17,23].…”